A Study of M802 (HER2 and CD3) in HER2-Positive Advanced Solid Tumors

Condition:   HER2-Positive Solid Tumors Interventions:   Drug: Chort 1 of M802;   Drug: Chort 2 of M802;   Drug: Cohort 3 of M802;   Drug: Cohort 4 of M802;   Drug: Cohort 5 of M802;   Drug: Cohort 6 of M802;   Drug: Cohort 7 of M802;   Drug: Cohort 8 of M802 Sponsor:   Wuhan YZY Biopharma Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: HER2 | Research | Study